Related Experiment Video
Updated: Sep 18, 2025

Field-Deployable Candidatus Liberibacter asiaticus Detection Using Recombinase Polymerase Amplification Combined with CRISPR-Cas12a
Published on: December 23, 2022
Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system
Yingjie Song1, Qiang Hu1, Yao Han1
1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.
Introduction:
Polymyxins are reserved as an ultimate defense against multidrug-resistant bacteria. The emergence of the polymyxin resistance gene mcr-1 poses a potential risk for the treatment of severe infections caused by Gram-negative bacteria. Timely detection and monitoring the mcr-1 gene are essential for guiding anti-infective therapy and controlling the spread of polymyxin resistance. Quantitative real-time PCR (qPCR) is one of the common methods for detecting resistance genes. However, qPCR has equipment dependency, and is not feasible in primary healthcare settings. Currently, there remains a lack of a highly sensitive and portable method for detecting the mcr-1 gene.
Methods:
We established and optimized detection assays of the mcr-1 gene based on CRISPR/Cas13a system and lateral flow strips. The detection method was preliminarily evaluated using clinical isolates from Escherichia coli, compared with qPCR.
Results:
The method for detecting the mcr-1 gene based on the CRISPR/Cas13a system and lateral flow strips was established, with a detection limit of 100 copies/mL. This method demonstrated high analytical specificity, with no cross-reactivity detected in non-mcr-1 and non-resistant strains. Among 36 clinical isolates, the method identified 31 strains as positive for the mcr-1 gene, and had a 100% concordance rate with the results of qPCR.
Conclusions:
We established a detection method for the polymyxin resistance mcr-1 gene based on the CRISPR/Cas13a system. This method enables visual readouts without instruments, making it potentially applicable to primary healthcare settings and field surveillance.
Insights
A new CRISPR/Cas13a assay with lateral flow strips can detect the polymyxin resistance gene mcr-1. This portable method is suitable for primary healthcare and field surveillance of multidrug-resistant bacteria.
Area of Science:
- Microbiology
- Molecular Biology
- Antimicrobial Resistance
Background:
- Polymyxins are crucial for treating multidrug-resistant Gram-negative bacterial infections.
- The emergence of the mcr-1 gene confers polymyxin resistance, posing a significant threat to public health.
- Accurate and rapid detection of mcr-1 is essential for guiding treatment and controlling resistance spread.
Purpose of the Study:
- To develop a sensitive and portable method for detecting the mcr-1 gene.
- To evaluate the performance of the developed assay compared to quantitative real-time PCR (qPCR).
Main Methods:
- CRISPR/Cas13a system combined with lateral flow strips was utilized for mcr-1 gene detection.
- Assay optimization and validation were performed using clinical isolates of Escherichia coli.
- Comparison with qPCR was conducted to assess accuracy and concordance.
Main Results:
- A detection limit of 100 copies/mL was achieved for the mcr-1 gene.
- The assay demonstrated high analytical specificity, with no cross-reactivity observed.
- 100% concordance with qPCR results was observed for 36 clinical isolates, correctly identifying 31 mcr-1 positive strains.
Conclusions:
- A novel CRISPR/Cas13a-based detection method for the mcr-1 gene was successfully established.
- The assay provides visual readouts without requiring specialized equipment, enhancing portability.
- This method holds potential for application in primary healthcare settings and field surveillance of polymyxin resistance.
More Related Videos
07:59Rapid and Specific Detection of Acinetobacter baumannii Infections Using a Recombinase Polymerase Amplification/Cas12a-based System
Published on: April 25, 2025
10:16Author Spotlight: Development of Simplified CRISPR-Based Tests for Rapid Detection of Infectious Diseases
Published on: August 16, 2024
Related Concept Videos
CRISPR
CRISPR and crRNAs
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
CRISPR/Cas9 Genome Editing
The Antiviral System of Bacteria and Archaea: CRISPR